Van Damme-Lombaerts R - Search Results

1

Pharmacokinetics of tacrolimus in stable paediatric renal transplant recipients.

Claeys T, Van Dyck M, Van Damme-Lombaerts R. Claeys T, et al. Pediatr Nephrol. 2010 Feb;25(2):335-42. doi: 10.1007/s00467-009-1331-6. Epub 2009 Nov 3. Pediatr Nephrol. 2010. PMID: 19885684

2

Tacrolimus dose requirements in paediatric renal allograft recipients are characterized by a biphasic course determined by age and bone maturation.

Knops N, Herman J, van Dyck M, Ramazani Y, Debbaut E, van Damme-Lombaerts R, Levtchenko E, van den Heuvel LP, Fieuws S, Kuypers D. Knops N, et al. Among authors: van damme lombaerts r. Br J Clin Pharmacol. 2017 Apr;83(4):863-874. doi: 10.1111/bcp.13174. Epub 2016 Dec 13. Br J Clin Pharmacol. 2017. PMID: 27966227 Free PMC article.

3

Reversible arterial spasm in an adolescent with primary oxalosis.

van Damme-Lombaerts R, Proesmans W, Alexandre G, van Dyck M, Serrus M, Wilms G. van Damme-Lombaerts R, et al. Clin Nephrol. 1988 Oct;30(4):235-8. Clin Nephrol. 1988. PMID: 3063419 Review.

4

Impact of growth hormone treatment on a Belgian population of short children with renal allografts.

Janssen F, Van Damme-Lombaerts R, Van Dyck M, Hall M, Schurmans T, Herman J, Hooghe L, Van Damme B. Janssen F, et al. Pediatr Transplant. 1997 Nov;1(2):190-6. Pediatr Transplant. 1997. PMID: 10084780

5

Sandimmune to Neoral conversion and value of abbreviated AUC monitoring in stable pediatric kidney transplant recipients.

Kelles A, Herman J, Tjandra-Maga TB, Van Damme-Lombaerts R. Kelles A, et al. Pediatr Transplant. 1999 Nov;3(4):282-7. doi: 10.1034/j.1399-3046.1999.00058.x. Pediatr Transplant. 1999. PMID: 10562972

6

Multicentre prospective randomised trial of tacrolimus, azathioprine and prednisolone with or without basiliximab: two-year follow-up data.

Webb NJ, Prokurat S, Vondrak K, Watson AR, Hughes DA, Marks SD, Moghal NE, Fitzpatrick MM, Milford DV, Saleem MA, Jones CA, Friman S, Van Damme-Lombaerts R, Janssen F, Hamer C, Rhodes S. Webb NJ, et al. Pediatr Nephrol. 2009 Jan;24(1):177-82. doi: 10.1007/s00467-008-0931-x. Epub 2008 Aug 8. Pediatr Nephrol. 2009. PMID: 18688657 Clinical Trial.

7

Effects of recombinant human growth hormone on graft function in renal-transplanted children and adolescents: the three-year experience of a Belgian study group.

Janssen F, Van Damme-Lombaerts R, Van Dyck M, Hall M, Proesmans W, Goos G, Kinnaert P. Janssen F, et al. Transplant Proc. 1993 Feb;25(1 Pt 2):1049-50. Transplant Proc. 1993. PMID: 8442037 No abstract available.

8

Single-dose pharmacokinetics and tolerability of everolimus in stable pediatric renal transplant patients.

Van Damme-Lombaerts R, Webb NA, Hoyer PF, Mahan J, Lemire J, Ettenger R, McMahon L, Cambon N, Boger R, Kovarik JM; Everolimus Study Group. Van Damme-Lombaerts R, et al. Pediatr Transplant. 2002 Apr;6(2):147-52. doi: 10.1034/j.1399-3046.2002.01070.x. Pediatr Transplant. 2002. PMID: 12000472 Clinical Trial.

9

Long-term cyclosporin A pharmacokinetic profiles in pediatric renal transplant recipients.

Kelles A, Van Damme-Lombaerts R, Tjandra-Maga TB, Van Damme B. Kelles A, et al. Transpl Int. 1996;9(6):546-50. doi: 10.1007/BF00335553. Transpl Int. 1996. PMID: 8914233

10

Erythropoietin treatment in children with renal failure.

Van Damme-Lombaerts R, Herman J. Van Damme-Lombaerts R, et al. Pediatr Nephrol. 1999 Feb;13(2):148-52. doi: 10.1007/s004670050584. Pediatr Nephrol. 1999. PMID: 10229005 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page